The Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.
If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.
"This conference series gets better and better every year,
demonstrating and tracking the progress of the microbiome therapeutics field.
Certainly the best conference on this theme that I have attended in my 10+ years in the field."
Gerard Honig
Crohn’s & Colitis Foundation
Highlights From Our 2019 Meeting
Thank you to everyone who joined us in 2019 and made the meeting such a resounding success.
We were honored to welcome 260+ microbiome thought-leaders from large pharma, biotech and the broader research community to discuss the greatest challenges and opportunities in developing targeted microbiome-based therapeutics, biomarkers and diagnostics.
You can view our infographic of event highlights here.
Additionally, register your interest to receive agenda and speaker updates for the 2020 program as they are announced.
Hear What Our Customers Say
"As a newcomer to the microbiome field, this conference provided an excellent overview.”
Richard Shanksky
Seres Therapeutics
“It was a great conference to effectively learn the current trends in microbiome drug development around the world.”
Nanae Izumi
Daiichi Sankyo
2019 Partners Included
Expertise Partners:
Industry Partner:
Other Confirmed Partners:
Other Events In The Series
